🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vaccines are one of our most effective public health tools but many who nee...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02057263
Treatments Being Tested
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
This study aims to develop innovative immunological read-outs and new techn...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-25
Trial ID
NCT01777295
The study is designed to see if a course of injections containing the NY-ES...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2009-02
Trial ID
NCT00821652
Prospective, randomized, double-blind, multicentre, placebo-controlled clin...
Status
Completed
Location
All India Institute of Medical Sciences (AIIMS)
Start Date
2021-09-22
Trial ID
NCT04919239
The central premise of our program is that durable control of HIV in the ab...
Status
Completed
Location
University of California, Los Angeles
Start Date
2018-08-01
Trial ID
NCT03606213
Treatments Being Tested
Inflammatory bowel disease (IBD) has witnessed a rising incidence globally ...
Status
Completed
Location
Queen Mary Hospital
Start Date
2019-08-12
Trial ID
NCT04083157
RATIONALE: Hepatitis B antigen peptide (HBsAg) vaccine may help the body bu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01292421
Treatments Being Tested
The purpose of this study is to assess the safety, reactogenicity and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-31
Trial ID
NCT01678677
Treatments Being Tested
The purpose of this Phase 3, observer-blind, placebo-controlled, multi-cent...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-23
Trial ID
NCT00616928
Treatments Being Tested